Characterization of Exosomes Platelets-released (EXOPLT)

Centro Cardiologico Monzino

Status: Enrolling

Conditions: Platelet Thrombus

Study type: Observational

Funder types: Other

Identifiers

NCT06298682

CCM1421

Details and patient eligibility

About

Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.

Full description

This study is a multicentre, observational. We plan to enrol 54 subjects from Centro Cardiologico Monzino IRCCS, and 121 buffy coat related to 121 subjects from Centro Trasfusionale Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. biographical and anthropomorphic data will be recorded, a fasting blood venous sample (from ante-cubital vein) will be collected for the haematochemical analyses and for research samples.

Enrollment: 175 estimated patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• subjects without known pathologies

Exclusion criteria

• individuals with gastrointestinal diseases,
• individuals with history of hepatic diseases,
• individuals with history of urogenital diseases,
• individuals with history of hematological diseases,
• individuals with history of immunological diseases,
• individuals with history of renal diseases,
• individuals with history of metabolic diseases
• individuals with history of respiratory diseases
• individuals with history of cancer
• individuals with history of cardiovascular disease
• individuals having permanent organ damage
• individuals with major trauma in the last 6 months prior to enrollment
• individuals with surgery in the last 6 months prior to enrollment
• individuals taking medication in the 15 days prior to enrolment.

Trial design

175 participants in 1 patient group

subjects without known pathologies